Nicholas Denton, PhD
Senior Lecturer
Professional Interests
Biography
Dr. Denton earned his PhD and BS in biomedical science from The Ohio State University, accumulating nearly a decade of experience investigating oncolytic virus therapy, tumor angiogenesis, and cancer immunology at Ohio State and Nationwide Children's Hospital before joining the teaching faculty. He directs the Pharmaceutical Sciences Teaching Laboratory and the lab courses offered at the College of Pharmacy in addition to instructing survey courses in pharmaceutical science research and cancer research. Dr. Denton advocacy for undergraduate research experiences extends beyond didactic teaching to administrating undergraduate research fellowships, serving under the research programs committee, judging research forums, and advising undergraduate research apprenticeships. As a Senior Affiliate to the Drake Institute of Teaching and Learning, Dr. Denton provides professional development to faculty and trainees on education research and evidence-based teaching practices. Dr. Denton is nationally recognized by the American Society of Pharmacology and Experimental Therapeutics for early career contributions to pharmacology education (2023) and from Hypothes.is as an innovator in social annotation for health science education (2023).
Dr. Denton's teaching practice is primarily in the Bachelors of Science in Pharmaceutical Sciences program. In directing the pharmaceutical sciences training laboratory, he develops authentic course-based research experiences to develop metacognition, inquiry, and teamwork skills in addition to pharmaceutical science content. As an advocate for undergraduate research, Dr. Denton teaches research survey courses in pharmaceutical science research and cancer research to elucidate the research process to students and develop students' scientist identity through research literacy and career exposure. Dr. Denton's non-didactic teaching practice includes facilitating workshops for interprofessional experiences, DEI professional development, new faculty orientation and communities of practice such as the Teaching as Research cohort.
Dr. Denton's research interests in discipline-based education research and the scholarship of teaching and learning reflects his teaching philosophy to empower student innovation and advance inclusive teaching practices. This includes regular talks at national conferences on subjects ranging from educational technology applications, to metacognitive coaching, to inquiry-team-based learning, to curricular learning analytics, to student wellness, and cultural competency. Dr. Denton's service on the American Association of Colleges of Pharmacy also includes scholarship committees investigating social determinants of health educational tools, DEI curricular mapping, and other climate surveys.
Education
- 2013, BS Health and Rehabilitation (Biomedical Science), The Ohio State University
- 2018, PhD, Biomedical Sciences, The Ohio State University
Honors
- 2023, OSU Undergraduate Research Access Innovation Seed Grant
- 2023, Hypothes.is Social Innovator- Health Sciences Award
- 2023, OSU College of Pharmacy Cassady Hale Award
- 2023, American Society for Pharmacology and Experimental Therapeutics Early Career Award in Pharmacology Education
- 2023, American Association of Colleges of Pharmacy SoTL Grant
- 2022, OSU Interdisciplinary Innovation Team Development Award
- 2022, OSU Student Academic Success Research Grant
- 2021, OSU Instructional Redesign Teaching Support Program Award
- 2021, OSU College of Pharmacy Teaching PEARL Award
- 2020, OSU Writing Across the Curriculum Meaningful Inquiry Grant
- 2020, OSU Drake Institute of Teaching and Learning Research and Implementation Grant
- 2019, OSU UITL Scholarship of Teaching and Learning Community Fellowship
Publications
- Inquiry-Team-Based Lab Course Design Enhances Underrepresented Undergraduate Predictors of Persistence in the Sciences, Medical Science Educator. 2024 Mar | journal-article. doi: 10.1007/s40670-024-02014-y.
- Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment., Molecular therapy oncolytics. 2018 Oct | journal-article. doi: 10.1016/j.omto.2018.10.001.
- Pediatric Cancer Immunotherapy: Opportunities and Challenges., Paediatric drugs. 2018 Oct | journal-article. doi: 10.1007/s40272-018-0297-x.
- Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?, Biomedicines. 2016 Jul | journal-article. doi: 10.3390/biomedicines4030013.
- Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children., Molecular therapy oncolytics. 2015 Sep | journal-article. doi: 10.1038/mto.2015.15.
- Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children., Molecular therapy oncolytics. 2015 Sep | journal-article. doi: 10.1038/mto.2015.16.
- Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity., Molecular therapy oncolytics. 2015 Jan | journal-article. doi: 10.1038/mto.2014.10.
- SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma., Oncotarget. 2014 Oct | journal-article. doi: 10.18632/oncotarget.2232.
- Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma., Molecular therapy : the journal of the American Society of Gene Therapy. 2013 Jun | journal-article. doi: 10.1038/mt.2013.114.